Trials / Completed
CompletedNCT02769910
Effects of High-concentration Topical Capsaicin on Histaminergic and Non-histaminergic Itch
The Role of Pre-established Skin Inflammation on the Susceptibility to Histamine and Cowhage-induced Itch in Healthy Humans
- Status
- Completed
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 16 (actual)
- Sponsor
- Hjalte Holm Andersen · Academic / Other
- Sex
- All
- Age
- 18 Years – 60 Years
- Healthy volunteers
- Accepted
Summary
The purpose of this project is to investigate the effect of capsaicin-induced neurogenic inflammation with three different intensities on itch subsequently induced by histamine and cowhage. The hypothesis is that capsaicin-induced pre-established neurogenic inflammation significantly increases susceptibility to itch provocations with cowhage and histamine.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Capsaicin 24 Hours | Dermal patches for transdermal application of Capsaicin, applied for 24 hours |
| DRUG | Capsaicin 1 Hour | Dermal patches for transdermal application of Capsaicin, applied for 1 hour |
| OTHER | Qutenza Demo Patch | Dermal patches mimicking active Qutenza patches. Used as control in comparison of Capsaicin efficacy. Applied for 24 hours. |
Timeline
- Start date
- 2016-05-01
- Primary completion
- 2016-07-01
- Completion
- 2016-07-01
- First posted
- 2016-05-12
- Last updated
- 2016-11-22
Locations
1 site across 1 country: Denmark
Source: ClinicalTrials.gov record NCT02769910. Inclusion in this directory is not an endorsement.